Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

NASDAQ:CABA

Overview | Financials
Company Name Cabaletta Bio, Inc.
Symbol CABA
Currency USD
Price 1.63
Market Cap 146,607,253
Dividend Yield 0%
52-week-range 0.986 - 8.77
Industry Biotechnology
Sector Healthcare
CEO Dr. Steven A. Nichtberger M.D.
Website https://www.cabalettabio.com

An error occurred while fetching data.

About Cabaletta Bio, Inc.

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or

Related Stocks

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

0.74 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

12.648 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

35.75 USD

Immunome, Inc. logo

Immunome, Inc.

IMNM

8.84 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

1.94 USD

Financials

Numbers are in millions USD

Numbers are in millions USD